700 per cent returns: Board announced stock split of equity shares; FIIs increased stake!

Shares of this company have gained more than 40 per cent in the last six months.

J B Chemicals & Pharmaceuticals Limited informed in the exchange filing that the company’s board has approved a Split or Sub-Division of 1(One) equity share having a face value of Rs 2/- (Rupees Two Only) each into 2(Two) equity shares having a face value of Rs 1/- (Rupees One Only) each. The record date for the sub-division of the equity shares is fixed on, September 18, 2023.

J B Chemicals & Pharmaceuticals Limited has delivered multibagger returns to its shareholders in the last three years. During this period, shares of J B Chemicals & Pharmaceuticals Limited surged from Rs 784.45 on September 04, 2020, to Rs 2857.75 on August 30, 2023, an increase of about 260 per cent in a one-year holding period. In the last five years, the shares of the company gained over 700 per cent.

Furthermore, in Q1FY24, the company posted strong Quarterly Results. The revenue of the company stood at Rs 896.20 crore which increased by 14.19 per cent YoY. The operating profit of the company stood at Rs 237.74 crore, which increased by 36.91 per cent YoY, while the PAT of the company increased by 35.29 per cent YoY, staying at Rs 142.32 crore. In Q1FY24, FIIs increased their stake in the company from 8.62 per cent to 9.53 per cent.

J.B. Chemicals and Pharmaceuticals Limited is one of India's leading pharmaceutical companies. The company manufactures a wide range of pharmaceutical formulation specialities, radio-diagnostics, APIs and intermediates. The manufacturing units are in Ankleshwar, Panoli and Daman.

The stock has shown tremendous growth and investors should keep a close eye on this stock.